Quoin Pharmaceuticals, Ltd. (QNRX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 24.93K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -24.93K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 5.09M | 4.52M | 4.02M | 3.79M | 3.96M | 2.41M | 2.53M | 2.14M | 2.46M | 2.22M | 2.13M | 2.26M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.69M | 1.42M | 1.74M | 1.74M | 1.58M | 1.33M | 1.36M | 1.55M | 1.57M | 1.39M | 1.37M | 1.63M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 3.4M | 3.1M | 2.28M | 2.05M | 2.37M | 1.07M | 1.17M | 587.5K | 885.3K | 832.39K | 758.76K | 625.1K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.12M | -4.52M | -4.02M | -3.79M | -3.96M | -2.41M | -2.53M | -2.14M | -2.46M | -2.22M | -2.13M | -2.26M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -29.32% | -87.96% | -59.02% | -77.49% | -60.97% | -8.45% | -18.95% | 5.44% | 11.43% | -6.32% | 8.69% | 15.3% |
| EBITDA | -5.09M | -4.5M | -3.99M | -3.77M | -3.93M | -2.38M | -2.5M | -2.11M | -2.43M | -2.19M | -2.1M | -2.23M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -29.51% | -88.88% | -59.61% | -78.41% | -61.6% | -8.58% | -19.24% | 5.46% | 11.5% | -6.41% | 8.79% | 15.45% |
| D&A (Non-Cash Add-back) | 24.93K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 25.67K | 26.01K | 26.01K |
| EBIT | -5.12M | -4.52M | -3.95M | -3.79M | -3.96M | -2.41M | -2.53M | -2.14M | -2.46M | -2.05M | -2.13M | -2.26M |
| Net Interest Income | 146.38K | 171.7K | 0 | 105.39K | 144.87K | 109.33K | 146.39K | 165.26K | 137.51K | 158.55K | 196.43K | 187.59K |
| Interest Income | 146.38K | 171.7K | 0 | 105.39K | 144.87K | 109.33K | 146.39K | 165.26K | 137.51K | 158.55K | 196.43K | 187.59K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 133.11K | 172.06K | 71.76K | 97.24K | 145K | 93.79K | 178.12K | 163.09K | 131K | 167.79K | 198.54K | 153.12K |
| Pretax Income | -4.98M | -4.35M | -3.95M | -3.7M | -3.81M | -2.31M | -2.35M | -1.97M | -2.33M | -2.05M | -1.93M | -2.11M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -4.98M | -4.35M | -3.95M | -3.7M | -3.81M | -2.31M | -2.35M | -1.97M | -2.33M | -2.05M | -1.93M | -2.11M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -30.74% | -88.14% | -68.02% | -87.23% | -63.8% | -12.75% | -21.97% | 6.31% | 10.59% | -2.44% | 36.4% | 21.03% |
| Net Income (Continuing) | -4.98M | -4.35M | -3.95M | -3.7M | -3.81M | -2.31M | -2.35M | -1.97M | -2.33M | -2.05M | -1.93M | -2.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.54 | -2.92 | -6.71 | -6.28 | -6.50 | -12.41 | -16.45 | -0.39 | -1.12 | -2.10 | -1.95 | -2.13 |
| EPS Growth % | 60.92% | 76.47% | 59.21% | -1510.26% | -480.36% | -490.95% | -743.59% | 81.69% | 53.72% | 57.06% | 85.7% | 78.09% |
| EPS (Basic) | -2.54 | -2.92 | -6.71 | -6.28 | -6.50 | -12.37 | -16.45 | -0.39 | -1.12 | -2.10 | -1.95 | -2.13 |
| Diluted Shares Outstanding | 1.96M | 1.5M | 588.17K | 588.17K | 586.33K | 186.51K | 5M | 5.05M | 2.1M | 987.22K | 987.22K | 987.22K |
| Basic Shares Outstanding | 1.96M | 1.5M | 588.17K | 588.17K | 586.33K | 186.51K | 5M | 5.05M | 2.1M | 987.22K | 987.22K | 987.22K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |